Injectafer for intravenous use [prescribing information]. Shirley, NY: American Regent; April 2024. 2. Venofer injection [prescribing
The majority of patients (93 to 95 percent) in trials of Injectafer received the target dose of 1500 mg. The full prescribing information for Injectafer is
Feraheme Prescribing Information. AMAG Pharmaceuticals, Inc. Waltham, MA. September 2024. 3. Injectafer Prescribing Information. American Regent, Inc
See prescribing information for details. Below is information regarding Injectafer. Medicaid and NCHC shall cover ferric carboxymaltose only
The full prescribing information for Injectafer is available at: The safety
General information about the safe and effective use of Injectafer. Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. You can ask your pharmacist or healthcare provider for information about Injectafer that is written for health professionals.
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Injectafer safely and effectively. See full prescribing information for Injectafer. H. INJECTAFER (ferric carboxymaltoseinjection), for intravenous u se -Initial U.S. Approval: 2024 -
Opinions re: Injectafer's Prescribing Information. Defendants contend that Wolf's testimony regarding the adequacy of the content of
Sections or subsections omitted from the full prescribing information are not . General information about using INJECTAFER safely and effectively.
Comments